Capital World Investors Io Biotech, Inc. Transaction History

Capital World Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.88 - $2.98 $1.23 Million - $1.95 Million	-652,812 Reduced 60.94%	418,499 $786,000
Q4 2022 Feb 14, 2023	SELL	$2.22 - $3.1 $363,389 - $507,435	-163,689 Reduced 13.25%	1,071,311 $2.46 Million
Q1 2022 May 19, 2022	BUY	$3.73 - $8.74 $4.61 Million - $10.8 Million	1,235,000 New	1,235,000 $6.55 Million
Q1 2022 May 16, 2022	SELL	$3.73 - $8.74 $4.61 Million - $10.8 Million	-1,235,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.4 - $15.65 $7.9 Million - $19.3 Million	1,235,000 New	1,235,000 $8.11 Million

23.6M

Ticker IOBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,815,300
Market Cap $26.5M
Description
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.